114 results
Page 5 of 6
S-4/A
EX-10.19
va6ktsfqs1thunuw
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
wtjh ptywdst
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
8-K
EX-99.1
105vear
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
EX-99.1
qvtc5m0uju k7yo4
28 Apr 21
Business combination disclosure
5:11pm
425
z4fjqt4l8m4chuqgi
28 Apr 21
Business combination disclosure
5:11pm
UPLOAD
dbsmuhd7bkj5ysdf5xu
20 Apr 21
Letter from SEC
12:00am
S-4
EX-10.7
lwdpen7
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.10
8w4d2382kdmrhtkla
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
0ca 6w4tc2tbs
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
6a9dlumogqfho3uj
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
b865ab3oihhmcboya7
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.14
ob7ie4y63wxt cgdsg2
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.11
c2cji7sx jn
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
91c3hzm 5ti
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K/A
EX-10.1
1edw8f60 ae
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
xbmhn3 vs
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
EX-99.1
lemh1
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
3d0dol8it zouxpv0
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
ispeytubyp7rl4s1
5 Mar 21
Annual report
8:13am
8-K
EX-1.1
2svfq
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm